Vantobra 170 mg, Lösung für einen Vernebler

7680685390011 CH-68539 Lösung
Vantobra 170 mg, Lösung für einen Vernebler
Vantobra 170 mg, Lösung für einen Vernebler
Vantobra 170 mg, Lösung für einen Vernebler
1 / 3
google

Article details

Package size
56
Selling units
56
Measure
Ampulle(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/01/2024
Patient information leaflet
Français
19/01/2024
Patient information leaflet
Italien
19/01/2024
Summary of Product Characteristics
Allemand
19/01/2024
Summary of Product Characteristics
Français
19/01/2024
Summary of Product Characteristics
Italien
19/01/2024

Detailed composition

Substance Quantity Type Category
(N/A)
170.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 2236.60
Specialties list
Yes
Generic
No
SL addition date: 01/05/2023

Authorization holder

PARI Swiss AG

6330 Cham

Authorization information

Swissmedic authorization number
68539
Drug name
Vantobra, Lösung für einen Vernebler
Galenic form
LSVE
ATC Code
J01GB01
Authorization status
Z
Dispensing category
A
First authorization
11/10/2022
Authorization expiration date
10/10/2027
IT Number
08.01.7.
Domain
Human medicine
Field of application
Chronische Infektion der Lunge mit Pseudomonas aeruginosa bei Patienten mit Mukoviszidose

Package details

Description (FR)
VANTOBRA sol inhal 170 mg/1.7ml amp 56 pce
Description (DE)
VANTOBRA Inhal Lös 170 mg/1.7ml Amp 56 Stk
Market launch
11/10/2022
Narcotic (BTM)
No